Sergio Mangiafico

Title: The Innovative Contributions of Sergio Mangiafico

Introduction

Sergio Mangiafico is a notable inventor based in Catania, Italy, recognized for his significant contributions to the field of ophthalmic formulations. With a total of four patents to his name, Mangiafico has focused on developing stable and effective topical ophthalmic solutions.

Latest Patents

Among his latest patents, Mangiafico has developed chemically and physically stable topical ophthalmic nepafenac-based formulations. These formulations are designed to maintain stability from both chemical and physical perspectives. Additionally, he has created aqueous ophthalmic formulations based on azithromycin. This invention involves topical ophthalmic preparations in the form of eye drops, which contain azithromycin as the active ingredient. The azithromycin is solubilized and stabilized using β-cyclodextrins, particularly sulfobutyl ether β-cyclodextrin (SBE-β-CD). These preparations exhibit remarkable stability, allowing for storage at room temperature for the intended shelf life of a commercial pharmaceutical product.

Career Highlights

Sergio Mangiafico has worked with several companies throughout his career, including Medivis S.r.l. and Trb Chemedica International S.a. His work in these organizations has contributed to advancements in pharmaceutical formulations, particularly in the ophthalmic sector.

Collaborations

Mangiafico has collaborated with notable colleagues such as Danilo Aleo and Maria Grazia Antonietta Saita. These partnerships have further enhanced his research and development efforts in the field of ophthalmology.

Conclusion

Sergio Mangiafico's innovative work in ophthalmic formulations has led to the development of stable and effective solutions that benefit the pharmaceutical industry. His contributions continue to impact the field positively.